Human cytomegalovirus (HCMV) infection, the most common cause of congenital disease
globally, affecting an estimated 1 million newborns annually, can result in lifelong sequelae …

Human cytomegalovirus (HCMV) glycoprotein B (gB) is a class III membrane fusion protein
required for viral entry. HCMV vaccine candidates containing gB have demonstrated …

Congenital cytomegalovirus (cCMV) is the most common infectious cause of disability in
children, including sensorineural hearing loss. There is interest in developing a pre …

Human cytomegalovirus (HCMV) is a β-herpesvirus that poses severe disease risk for
immunocompromised patients who experience primary infection or reactivation …

Introduction Cytomegalovirus (CMV) is the most common cause of congenital infection and
affected children often have permanent neurodevelopmental sequelae, including hearing …

In the absence of effective vaccines, human-infecting members of the Herpesvirus family
cause considerable morbidity and mortality worldwide. Herpesvirus infection relies on …

Human cytomegalovirus (HCMV) is the leading infectious cause of birth defects. Despite the
global disease burden, there is no FDA-approved HCMV vaccine. The most efficacious …

Human cytomegalovirus (HCMV) is a β-herpesvirus that poses severe risk for
immunocompromised patients. Development and optimization of effective anti-HCMV …